Table 1 Low-dose corticosteroid use by region and country
Region | Country* | Patients (N = 8,968) n (%) | Within Study LDC Use (N = 3,051) n (%) | Within Country LDC Use n (%) | Within Region LDC Use n (%) |
|---|---|---|---|---|---|
Europe†: |  | 2,184 (24.4) | 1,116 (36.6) |  | 1,116 (51.1) |
| Â | Poland | 181 (2.0) | 107 (3.5) | 107 (59.1) | Â |
| Â | Germany | 1,459 (16.3) | 754 (24.7) | 754 (51.7) | Â |
| Â | Belgium | 238 (2.7) | 91 (3.0) | 91 (38.2) | Â |
| Â | Other European Countries | 306 (3.4) | 164 (5.4) | 164 (53.6) | Â |
Latin America†: |  | 2,869 (32.0) | 1,063 (34.8) |  | 1,063 (37.1) |
| Â | Brazil | 856 (9.5) | 538 (17.6) | 538 (62.9) | Â |
| Â | Chile | 261 (2.9) | 112 (3.7) | 112 (42.9) | Â |
| Â | Peru | 222 (2.5) | 57 (1.9) | 57 (25.7) | Â |
| Â | Argentina | 973 (10.8) | 249 (8.2) | 249 (25.6) | Â |
| Â | Mexico | 368 (4.1) | 80 (2.6) | 80 (21.7) | Â |
| Â | Other Latin American Countries | 189 (2.1) | 27 (0.9) | 27 (14.3) | Â |
Northern America†: |  | 523 (5.8) | 139 (4.6) |  | 139 (26.6) |
| Â | United States/(Canada 1 ) | 523 (5.8) | 139 (4.6) | 139 (26.6) | Â |
Oceania†: |  | 683 (7.6) | 156 (5.1) |  | 156 (22.8) |
| Â | Australia | 557 (6.2) | 132 (4.3) | 132 (23.7) | Â |
| Â | Other Oceania Countries | 126 (1.4) | 24 (0.8) | 24 (19.0) | Â |
Asia†: |  | 2,547 (28.4) | 549 (18.0) |  | 549 (21.6) |
| Â | India | 681 (7.6) | 197 (6.5) | 197 (28.9) | Â |
| Â | Singapore | 188 (2.1) | 41 (1.3) | 41 (21.8) | Â |
| Â | Philippines | 411 (4.6) | 87 (2.9) | 87 (21.2) | Â |
| Â | Israel | 150 (1.7) | 29 (1.0) | 29 (19.3) | Â |
| Â | Malaysia | 522 (5.8) | 47 (1.5) | 47 (9.0) | Â |
| Â | Other Asian Countries | 595 (6.6) | 148 (4.9) | 148 (24.9) | Â |
Other Regions†: |  | 162 (1.8) | 28 (0.9) | 28 (17.3) | 28 (17.3) |